Avidity Partners Management LP Immunic, Inc. Transaction History
Avidity Partners Management LP
- $885 Million
- Q4 2024
A detailed history of Avidity Partners Management LP transactions in Immunic, Inc. stock. As of the latest transaction made, Avidity Partners Management LP holds 7,966,400 shares of IMUX stock, worth $8.36 Million. This represents 0.9% of its overall portfolio holdings.
Number of Shares
7,966,400
Previous 8,266,000
3.62%
Holding current value
$8.36 Million
Previous $13.6 Million
41.59%
% of portfolio
0.9%
Previous 0.84%
Shares
3 transactions
Others Institutions Holding IMUX
# of Institutions
75Shares Held
51.2MCall Options Held
824KPut Options Held
354K-
Bvf Inc San Francisco, CA8.9MShares$9.35 Million0.33% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT7.29MShares$7.66 Million0.51% of portfolio
-
Rtw Investments, LP New York, NY4.57MShares$4.8 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.92MShares$4.12 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X02.69MShares$2.82 Million0.0% of portfolio
About IMMUNIC, INC.
- Ticker IMUX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,565,000
- Market Cap $32.1M
- Description
- Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...